Health

Phase-III trial of favipiravir starts in Kathmandu and Pokhara

Originally made to treat the flu in Japan, the drug is currently being manufactured in Nepal itself. Phase-III trial of favipiravir starts in Kathmandu and Pokhara
Tablets of Avigan (generic name : Favipiravir), developed by drug maker Toyama Chemical Co at Fujifilm's headquarters in Tokyo. Reuters
bookmark
Arjun Poudel
Published at : December 10, 2020
Updated at : December 10, 2020 09:04
Kathmandu

Arjun Poudel

Arjun Poudel is a health reporter for The Kathmandu Post. Before joining the Post, he worked for Sagarmatha Television, Naya Patrika, Republica and The Himalayan Times.


×
Top